222 related articles for article (PubMed ID: 19304468)
1. A case of capecitabine-induced hyperpigmentation and radiation recall phenomenon.
Ghosal N; Misra V
Clin Oncol (R Coll Radiol); 2009 Oct; 21(8):632. PubMed ID: 19304468
[No Abstract] [Full Text] [Related]
2. [A woman with palmar and plantar hyperpigmentation].
van Tienhoven G; Wilmink JW
Ned Tijdschr Geneeskd; 2011; 155(45):A4100. PubMed ID: 22085578
[TBL] [Abstract][Full Text] [Related]
3. [Capecitabine-induced hyperpigmentation].
Vázquez-Bayo C; Rodríguez-Bujaldón AL; Jiménez-Puya R; Galán-Gutiérrez M; Moreno-Giménez JC
Actas Dermosifiliogr; 2007 Sep; 98(7):491-3. PubMed ID: 17669305
[TBL] [Abstract][Full Text] [Related]
4. [Capecitabine-induced hyperpigmentation followed by hand-foot syndrome: a new case report].
Agharbi FZ; Meziane M; Benhemmne H; Daoudi K; Elmesbahi O; Mikou O; Mernissi FZ
Ann Dermatol Venereol; 2012 Mar; 139(3):221-2. PubMed ID: 22401689
[No Abstract] [Full Text] [Related]
5. Capecitabine induced cutaneous hyperpigmentation: report of a case.
Pui JC; Meehan S; Moskovits T
J Drugs Dermatol; 2002 Sep; 1(2):202-5. PubMed ID: 12847748
[TBL] [Abstract][Full Text] [Related]
6. Capecitabine-induced coronary vasospasm.
Goldsmith YB; Roistacher N; Baum MS
J Clin Oncol; 2008 Aug; 26(22):3802-4. PubMed ID: 18669470
[No Abstract] [Full Text] [Related]
7. Actinic keratosis and capecitabine therapy.
Higa GM; Kovach RF; Abraham J
J Oncol Pharm Pract; 2005 Dec; 11(4):151-3. PubMed ID: 16595067
[TBL] [Abstract][Full Text] [Related]
8. Onycholysis with the appearance of a "sunset" secondary to capecitabine.
Maino KL; Norwood C; Stashower ME
Cutis; 2003 Sep; 72(3):234-6. PubMed ID: 14533836
[TBL] [Abstract][Full Text] [Related]
9. Granulomatous septal panniculitis associated with capecitabine (Xeloda).
Dalmau J; Roé E; Puig L; Alomar A
J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):121-2. PubMed ID: 18181993
[No Abstract] [Full Text] [Related]
10. Coronary artery spasm induced by capecitabine.
Sestito A; Sgueglia GA; Pozzo C; Cassano A; Barone C; Crea F; Lanza GA
J Cardiovasc Med (Hagerstown); 2006 Feb; 7(2):136-8. PubMed ID: 16645374
[TBL] [Abstract][Full Text] [Related]
11. Nursing considerations for capecitabine-based combination therapy.
Becze E
ONS Connect; 2009 Apr; 24(4):14-5. PubMed ID: 19413236
[No Abstract] [Full Text] [Related]
12. Capecitabine and PPE syndrome: a case report.
LoRusso PM
Breast J; 2003; 9(1):64-5. PubMed ID: 12558679
[No Abstract] [Full Text] [Related]
13. Capecitabine-induced hand-foot syndrome and cutaneous hyperpigmentation in an elderly vitiligo patient.
Tavares-Bello R
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1434-5. PubMed ID: 17958867
[No Abstract] [Full Text] [Related]
14. [Long-term response of liver metastases of breast cancer to capecitabine--case report].
Macková D
Klin Onkol; 2010; 23(1):46-8. PubMed ID: 20192074
[TBL] [Abstract][Full Text] [Related]
15. Uncontrolled hypertriglyceridemia induced by capecitabine: case report and review of the literature.
Bar-Sela G; Haim N
Cancer Chemother Pharmacol; 2009 Apr; 63(5):779-82. PubMed ID: 18641989
[TBL] [Abstract][Full Text] [Related]
16. [Severe capecitabine-associated toxicity in a patient carrying a mutation in the dihydropyrimidine dehydrogenase gen].
González-Haba E
Farm Hosp; 2012; 36(6):554-5. PubMed ID: 23461455
[No Abstract] [Full Text] [Related]
17. Tumor lysis syndrome following a single dose of capecitabine.
Kurt M; Eren OO; Engin H; Güler N
Ann Pharmacother; 2004 May; 38(5):902. PubMed ID: 15039470
[No Abstract] [Full Text] [Related]
18. Longitudinal melanonychia induced by capecitabine.
Paravar T; Hymes SR
Dermatol Online J; 2009 Oct; 15(10):11. PubMed ID: 19951629
[TBL] [Abstract][Full Text] [Related]
19. Severe hypertriglyceridaemia associated with the use of capecitabine.
Polinder-Bos HA; Kok EE; van de Wiel A; Spiering W; Wielders JP; Bloemendal HJ
Neth J Med; 2012 Mar; 70(2):104. PubMed ID: 22418760
[No Abstract] [Full Text] [Related]
20. Capecitabine-induced acute myeloid leukaemia.
Tansley S; Gibbons S
N Z Med J; 2009 May; 122(1294):118-9. PubMed ID: 19465957
[No Abstract] [Full Text] [Related]
[Next] [New Search]
